Curanex Pharmaceuticals Inc Common Stock (CURX) — Net Asset Quality Index
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Net Asset Quality Index of 98.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $14.48 Million minus total liabilities of $185.96K yields net assets of $14.29 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read CURX current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Curanex Pharmaceuticals Inc Common Stock Net Asset Quality Index Over Time (2022–2024)
This chart shows how Curanex Pharmaceuticals Inc Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the index stands at 98.7%, representing net assets of $14.29 Million against total assets of $14.48 Million USD. For live market cap and overall valuation, see CURX company net worth.
Annual Net Asset Quality Index for Curanex Pharmaceuticals Inc Common Stock (2022–2024)
The table below presents the year-by-year Net Asset Quality Index for Curanex Pharmaceuticals Inc Common Stock from 2022 to 2024, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See CURX net asset value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.2% | $503.36K | $517.93K | $14.57K | ▲ +16.4 pp |
| 2023 | 80.8% | $60.09K | $74.37K | $14.28K | ▼ -19.2 pp |
| 2022 | 100.0% | $10.23K | $10.23K | $0.00 | — |